Pfizer ups COVID-19 vaccine revenue estimates
Pfizer has upped its 2021 sales forecast for its mRNA COVID-19 vaccine to $26bn: as well as reporting strong Q1 results for the business overall this morning.
Archives for May 4, 2021
Lonza leverages learnings from earlier ramp-up of Moderna drug substance, looks to boost staffing levels
A new agreement with Moderna will see Lonza add three more production lines at its site in Visp, Switzerland.